Search company, investor...

Akshaya Bio

akshayabio.com

About Akshaya Bio

Akshaya Bio is a privately held development stage biotechnology company. Akshaya develops therapeutics for infectious diseases and cancer. Akshaya's proprietary Chimigen Platform Technology uses dendritic cell receptor-targeted chimeric molecules to develop a portfolio of biotherapeutic agents to meet major unmet medical needs such as treatments for chronic hepatitis B and hepatitis C virus infections, avian and swine influenza, alphavirus infections, malaria, HIV and cancer.

Headquarters Location

8223 Roper Road

Edmonton, Alberta, T6E 6S4,

Canada

780-431-9503

Missing: Akshaya Bio's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Akshaya Bio's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Akshaya Bio Patents

Akshaya Bio has filed 1 patent.

The 3 most popular patent topics include:

  • Antivirals
  • Immune system
  • Immunology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/7/2022

Immunology, Immune system, Antivirals, Vaccines, Transcription factors

Application

Application Date

1/7/2022

Grant Date

Title

Related Topics

Immunology, Immune system, Antivirals, Vaccines, Transcription factors

Status

Application

Latest Akshaya Bio News

Western Equine Encephalitis - Pipeline Review, H2 2016 - Key Players are Akshaya Bio, Altravax, EpiVax, H&P Labs & Profectus BioSciences - Research and Markets

Feb 9, 2017

Western Equine Encephalitis - Pipeline Review, H2 2016 - Key Players are Akshaya Bio, Altravax, EpiVax, H&P Labs & Profectus BioSciences - Research and Markets February 09, 2017 09:43 AM Eastern Standard Time DUBLIN--( BUSINESS WIRE )--Research and Markets has announced the addition of the "Western Equine Encephalitis - Pipeline Review, H2 2016" report to their offering. Western equine encephalitis is a disease that is spread to humans by infected mosquitoes. Western equine encephalitis is caused by the western equine encephalitis virus, an arbovirus. Symptoms range from mild to severe and may include only fever and headache to encephalitis with delirium, disorientation or coma. This report provides comprehensive information on the therapeutic development for Western Equine Encephalitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Western Equine Encephalitis and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Key Topics Covered:

Akshaya Bio Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Akshaya Bio Rank

Akshaya Bio Frequently Asked Questions (FAQ)

  • Where is Akshaya Bio's headquarters?

    Akshaya Bio's headquarters is located at 8223 Roper Road, Edmonton.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.